{"id":25841,"date":"2024-07-23T17:55:06","date_gmt":"2024-07-23T20:55:06","guid":{"rendered":"https:\/\/femama.org.br\/site\/sem-categoria\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/"},"modified":"2024-07-23T17:55:06","modified_gmt":"2024-07-23T20:55:06","slug":"incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate","status":"publish","type":"post","link":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/","title":{"rendered":"Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate!"},"content":{"rendered":"<p style=\"text-align: center;\"><span style=\"font-weight: 400; color: #000000;\">Divulgue e Participe das CONSULTAS P\u00daBLICAS n\u00b043 e 48 at\u00e9 05 de agosto!<\/span><\/p>\n<p> &nbsp;  <span style=\"font-weight: 400; color: #000000;\">Est\u00e3o abertas no site da Conitec as Consultas P\u00fablicas n\u00b043 e 48, para discutir a incorpora\u00e7\u00e3o da combina\u00e7\u00e3o de pertuzumabe e trastuzumabe em dose fixa subcut\u00e2nea (PHESGO\u00ae) no tratamento de c\u00e2ncer de mama HER2-positivo tanto em est\u00e1gios avan\u00e7ados como em tratamentos neoadjuvantes no SUS. Apesar dos relat\u00f3rios para a sociedade, elaborados pela Conitec, reconhecerem a qualidade e efic\u00e1cia do tratamento em avalia\u00e7\u00e3o, a recomenda\u00e7\u00e3o preliminar da comiss\u00e3o \u00e9 desfavor\u00e1vel \u00e0 incorpora\u00e7\u00e3o por raz\u00f5es econ\u00f4micas e or\u00e7ament\u00e1rias.<\/span>  <span style=\"font-weight: 400; color: #000000;\">A inova\u00e7\u00e3o na forma de administra\u00e7\u00e3o destes medicamentos traz benef\u00edcios como a redu\u00e7\u00e3o do tempo necess\u00e1rio para a aplica\u00e7\u00e3o do rem\u00e9dio e, por consequ\u00eancia, a diminui\u00e7\u00e3o dos impactos emocionais causados neste processo, oferecendo mais qualidade de vida \u00e0s pessoas que vivem a jornada do c\u00e2ncer. A incorpora\u00e7\u00e3o dessas tecnologias no SUS pode ampliar o acesso \u00e0s mesmas, possibilitando que mais pacientes oncol\u00f3gicos recebam o tratamento adequado.<\/span>  <span style=\"font-weight: 400; color: #000000;\">Para que as pol\u00edticas p\u00fablicas de sa\u00fade reflitam as necessidades e prefer\u00eancias dos pacientes diretamente impactados pelo tratamento oncol\u00f3gico, precisamos agir! Al\u00e9m de configurar o pleno exerc\u00edcio de nossa cidadania, a participa\u00e7\u00e3o em Consultas P\u00fablicas e demais espa\u00e7os democr\u00e1ticos permite que a perspectiva dos usu\u00e1rios seja considerada no processo decis\u00f3rio da pol\u00edtica p\u00fablica. Por isso \u00e9 fundamental que todos se engajem, participando e fazendo de cada viv\u00eancia um instrumento para fazer valer a nossa voz enquanto ferramenta de transforma\u00e7\u00e3o pol\u00edtica.\u00a0\u00a0\u00a0\u00a0<\/span>  &nbsp;  <span style=\"color: #000000;\"><b>O que s\u00e3o Consultas P\u00fablicas?<\/b><\/span>  <span style=\"font-weight: 400; color: #000000;\">As Consultas P\u00fablicas s\u00e3o um mecanismo de participa\u00e7\u00e3o social, de car\u00e1ter consultivo, realizado com prazo definido e aberto a qualquer interessado. Ou seja, \u00e9 um momento importante para trazermos a experi\u00eancia de quem trata ou vive com a doen\u00e7a, para que essas vozes sejam ouvidas e consideradas na tomada de decis\u00f5es relativas \u00e0 formula\u00e7\u00e3o e defini\u00e7\u00e3o de pol\u00edticas p\u00fablicas.<\/span>  <span style=\"color: #000000;\"><span style=\"font-weight: 400;\"> <\/span><b>Por que \u00e9 importante participar?<\/b><\/span>  <span style=\"font-weight: 400; color: #000000;\">As consultas p\u00fablicas s\u00e3o uma maneira direta de influenciar as decis\u00f5es que moldam o acesso aos tratamentos de sa\u00fade, participar delas \u00e9 uma forma de exercer cidadania e colocar em pr\u00e1tica seus direitos. \u00c9 importante se fazer presente e se posicionar para garantir que os servi\u00e7os p\u00fablicos atendam \u00e0s necessidades da popula\u00e7\u00e3o.\u00a0<\/span>  &nbsp;  <span style=\"color: #000000;\"><b>Saiba mais sobre as consultas e participe:<\/b><\/span>  <span style=\"color: #000000;\"><b>Consulta p\u00fablica n\u00ba 43<\/b><span style=\"font-weight: 400;\"> &#8211; Pertuzumabe e trastuzumabe em dose fixa subcut\u00e2nea para o tratamento metast\u00e1tico de pacientes com c\u00e2ncer de mama HER2-positivo em primeira linha: <\/span><\/span><a href=\"https:\/\/click.email-epicx.roche.com\/?qs=6c5d46ea7223942c2e019aa1705e382d6072454826b3b428f5cc68e2b65640866cc0481888e834f752852821af309adaf709931c34f49ee3\"><span style=\"font-weight: 400;\">https:\/\/www.gov.br\/participamaisbrasil\/consulta-publica-conitec-sectics-n-43-2024-pertuzumabe<\/span><\/a>  <span style=\"color: #000000;\"><b>Consulta p\u00fablica n\u00ba 48<\/b><span style=\"font-weight: 400;\"> &#8211;\u00a0 Pertuzumabe e trastuzumabe em combina\u00e7\u00e3o de dose fixa subcut\u00e2nea para tratamento neoadjuvante de pacientes com c\u00e2ncer de mama HER2-positivo: <\/span><\/span><a href=\"https:\/\/click.email-epicx.roche.com\/?qs=6c5d46ea7223942c88ffaf0e3b6e969d782f8274e9044c453d0de535324d090bc3f04eafca1ce57524cf221119dda064a66b99aa9aaf789c\"><span style=\"font-weight: 400;\">https:\/\/www.gov.br\/participamaisbrasil\/consulta-publica-conitec-sectics-n-48-2024-pertuzumabe-e-trastuzumabe<\/span><\/a>  &nbsp;  <span style=\"color: #000000;\"><b>Participe, a sua voz \u00e9 muito importante no controle do c\u00e2ncer! <\/b><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Divulgue e Participe das CONSULTAS P\u00daBLICAS n\u00b043 e 48 at\u00e9 05 de agosto! &nbsp; Est\u00e3o abertas no site da Conitec as Consultas P\u00fablicas n\u00b043 e 48, para discutir a incorpora\u00e7\u00e3o da combina\u00e7\u00e3o de pertuzumabe e trastuzumabe em dose fixa subcut\u00e2nea (PHESGO\u00ae) no tratamento de c\u00e2ncer de mama HER2-positivo tanto em est\u00e1gios avan\u00e7ados como em tratamentos [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":25842,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[19,18,20,13],"tags":[],"class_list":["post-25841","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-advocacy","category-cancer-de-mama","category-direito-dos-pacientes","category-noticias-recentes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate! | FEMAMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate! | FEMAMA\" \/>\n<meta property=\"og:description\" content=\"Divulgue e Participe das CONSULTAS P\u00daBLICAS n\u00b043 e 48 at\u00e9 05 de agosto! &nbsp; Est\u00e3o abertas no site da Conitec as Consultas P\u00fablicas n\u00b043 e 48, para discutir a incorpora\u00e7\u00e3o da combina\u00e7\u00e3o de pertuzumabe e trastuzumabe em dose fixa subcut\u00e2nea (PHESGO\u00ae) no tratamento de c\u00e2ncer de mama HER2-positivo tanto em est\u00e1gios avan\u00e7ados como em tratamentos [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/\" \/>\n<meta property=\"og:site_name\" content=\"FEMAMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/femamabrasil\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-23T20:55:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2024\/07\/post-site-30-1024x512.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Femama\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@femama_\" \/>\n<meta name=\"twitter:site\" content=\"@femama_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Femama\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/\"},\"author\":{\"name\":\"Femama\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\"},\"headline\":\"Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate!\",\"datePublished\":\"2024-07-23T20:55:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/\"},\"wordCount\":529,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/post-site-30.png\",\"articleSection\":[\"Advocacy\",\"C\u00e2ncer de Mama\",\"Direito dos Pacientes\",\"Not\u00edcias recentes\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/\",\"name\":\"Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate! | FEMAMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/post-site-30.png\",\"datePublished\":\"2024-07-23T20:55:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/#primaryimage\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/post-site-30.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/post-site-30.png\",\"width\":6912,\"height\":3456},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"name\":\"FEMAMA\",\"description\":\"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/femama.org.br\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\",\"name\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"width\":300,\"height\":92,\"caption\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/femamabrasil\",\"https:\\\/\\\/x.com\\\/femama_\",\"https:\\\/\\\/www.instagram.com\\\/femama.brasil\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/femamaorg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\",\"name\":\"Femama\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"caption\":\"Femama\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate! | FEMAMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/","og_locale":"pt_BR","og_type":"article","og_title":"Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate! | FEMAMA","og_description":"Divulgue e Participe das CONSULTAS P\u00daBLICAS n\u00b043 e 48 at\u00e9 05 de agosto! &nbsp; Est\u00e3o abertas no site da Conitec as Consultas P\u00fablicas n\u00b043 e 48, para discutir a incorpora\u00e7\u00e3o da combina\u00e7\u00e3o de pertuzumabe e trastuzumabe em dose fixa subcut\u00e2nea (PHESGO\u00ae) no tratamento de c\u00e2ncer de mama HER2-positivo tanto em est\u00e1gios avan\u00e7ados como em tratamentos [&hellip;]","og_url":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/","og_site_name":"FEMAMA","article_publisher":"https:\/\/www.facebook.com\/femamabrasil","article_published_time":"2024-07-23T20:55:06+00:00","og_image":[{"width":1024,"height":512,"url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2024\/07\/post-site-30-1024x512.png","type":"image\/png"}],"author":"Femama","twitter_card":"summary_large_image","twitter_creator":"@femama_","twitter_site":"@femama_","twitter_misc":{"Escrito por":"Femama","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/#article","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/"},"author":{"name":"Femama","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e"},"headline":"Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate!","datePublished":"2024-07-23T20:55:06+00:00","mainEntityOfPage":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/"},"wordCount":529,"commentCount":0,"publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"image":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2024\/07\/post-site-30.png","articleSection":["Advocacy","C\u00e2ncer de Mama","Direito dos Pacientes","Not\u00edcias recentes"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/","url":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/","name":"Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate! | FEMAMA","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/#primaryimage"},"image":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2024\/07\/post-site-30.png","datePublished":"2024-07-23T20:55:06+00:00","breadcrumb":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/#primaryimage","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2024\/07\/post-site-30.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2024\/07\/post-site-30.png","width":6912,"height":3456},{"@type":"BreadcrumbList","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/incorporacao-de-novos-medicamentos-para-cancer-de-mama-no-sus-estao-em-debate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/femama.org.br\/site\/"},{"@type":"ListItem","position":2,"name":"Incorpora\u00e7\u00e3o de novos medicamentos para c\u00e2ncer de mama no SUS est\u00e3o em debate!"}]},{"@type":"WebSite","@id":"https:\/\/femama.org.br\/site\/#website","url":"https:\/\/femama.org.br\/site\/","name":"FEMAMA","description":"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/femama.org.br\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/femama.org.br\/site\/#organization","name":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","url":"https:\/\/femama.org.br\/site\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","width":300,"height":92,"caption":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama"},"image":{"@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/femamabrasil","https:\/\/x.com\/femama_","https:\/\/www.instagram.com\/femama.brasil\/","https:\/\/www.youtube.com\/user\/femamaorg"]},{"@type":"Person","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e","name":"Femama","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","caption":"Femama"}}]}},"_links":{"self":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/25841","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/comments?post=25841"}],"version-history":[{"count":0,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/25841\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media\/25842"}],"wp:attachment":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media?parent=25841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/categories?post=25841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/tags?post=25841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}